Depressed responsiveness of phospholipase C isoenzymes to phosphatidic acid in congestive heart failure.
The cardiac sarcolemmal membrane cis -unsaturated fatty acid-sensitive phospholipase D hydrolyzes phosphatidylcholine to form phosphatidic acid. The functional significance of phosphatidic acid is indicated by its ability to increase [Ca(2+)](i)and augment cardiac contractile performance via the activation of phospholipase C. Accordingly, we tested the hypothesis that a defect occurs in the membrane level of phosphatidic acid and/or the responsiveness of cardiomyocytes to phosphatidic acid in congestive heart failure due to myocardial infarction. Myocardial infarction was produced in rats by ligation of the left coronary artery while sham-operated animals served as control. At 8 weeks after surgery, the experimental animals were at a stage of moderate congestive heart failure. Compared to sham controls, phosphatidic acid-mediated increase in [Ca(2+)](i), as determined by the fura 2-AM technique, was significantly reduced in failing cardiomyocytes. Immunoprecipitation of sarcolemmal phospholipase C isoenzymes using specific monoclonal antibodies revealed that the stimulation of phospholipase C gamma(1)and delta(1)phosphatidylinositol 4,5-bisphosphate hydrolyzing activities by phosphatidic acid was decreased in the failing heart. Although the activity of phospholipase C beta(1)in the failing heart was higher than the control, phosphatidic acid did not stimulate this isoform in control sarcolemma, and produced an inhibitory action in the failing heart preparation. Furthermore, the specific binding of phosphatidic acid to phospholipase C gamma(1)and delta(1)isoenzymes was decreased, whereas binding to phospholipase beta(1)was absent in the failing heart. A reduction in the intramembranal level of phosphatidic acid derived via cis -unsaturated fatty acid-sensitive phospholipase D was also seen in the failing heart. These findings suggest that a defect in phosphatidic acid-mediated signal pathway in sarcolemma may represent a novel mechanism of heart dysfunction in congestive heart failure.
Tappia
P S
PS
Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, Department of Human Anatomy and Cell Science, University of Manitoba, 351 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada. ptappia@sbrc.umanitoba.ca
Yu
C H
CH
Di Nardo
P
P
Pasricha
A K
AK
Dhalla
N S
NS
Panagia
V
V
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002413:Cations, Divalent; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006333:Heart Failure / Q000201:enzymology* / Q000378:metabolism / Q000503:physiopathology; D007527:Isoenzymes / Q000378:metabolism*; D008297:Male; D009203:Myocardial Infarction / Q000201:enzymology* / Q000378:metabolism; D010712:Phosphatidic Acids / Q000378:metabolism*; D054799:Phospholipase C beta; D054803:Phospholipase C delta; D051966:Phospholipase C gamma; D010739:Phospholipase D / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D010738:Type C Phospholipases / Q000378:metabolism*; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology
D002413:Cations, Divalent; D005231:Fatty Acids, Unsaturated; D007527:Isoenzymes; D010712:Phosphatidic Acids; D010738:Type C Phospholipases; D054799:Phospholipase C beta; D054803:Phospholipase C delta; C518035:Plcb1 protein, rat; C518026:Plcd1 protein, rat; D051966:Phospholipase C gamma; D010739:Phospholipase D; D002118:Calcium